Getting influenza raises heart attack risk, especially in seniors: study Cardiovascular risk peaks 30 days after starting LABA or LAMA therapy in COPDClose monitoring for cardiovascular symptoms recommended for new users of LABAs or LAMAs Canadian Thoracic Society issues COPD pharmacotherapy update Provides evidence-based recommendations for pharmacologic management of COPD New Canadian Thoracic Society statement focuses on severe asthma Provides guidance on management, including the role of new and emerging therapies Four things pharmacists should question about respiratory therapy Canadian Thoracic Society focuses on unnecessary tests and treatments, to improve care and reduce waste No link between desloratadine use and QT prolongation Safety review fails to find evidence of abnormal heart rhythm related to the antihistamine Regular probiotic use ineffective in preventing infant absence from daycare Study finds no beneficial effects of starting probiotics before entry into daycare High-dose vitamin D no better than standard dose for preventing kids' colds: study Asthma patient education needs improving in Canada Article examines barriers to effective delivery of asthma education and proposes solutions Boxed warning regarding serious neuropsychiatric events removed from Canadian Champix product monograph Advise patients to report new psychiatric symptoms while taking any smoking cessation meds, including varenicline First Previous 33 34 35 36 37 Next Last
